CCCR [China Commercial Credit] 8-K: EMPLOYMENT AGREEMENT Agreement” Effective Date Company Executive” Group

[EMPLOYMENT AGREEMENT Agreement” Effective Date Company Executive” Group This EMPLOYMENT AGREEMENT (the “ RECITALS A. The Company desires to employ the Executive as its Chief Executive Officer and President and to assure itself of the services of the Executive during the term of Employment (as defined below). B. The Executive desires to be employed by the Company as its Chief] []

By | 2016-03-16T18:06:10+00:00 December 31st, 2014|Categories: CCCR, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] CORRESP: (Original Filing)

[VIA EDGAR Division of Corporation Finance Mail Stop 4720 100 F Street, N.E. Attention: Brian Cascio, Accounting Branch Chief Andri Boerman December 31, 2014 Re: ChipMOS TECHNOLOGIES (Bermuda) LTD. Form 20-F for the Fiscal Year Ended December 31, 2013 Filed April 25, 2014 File No. 000-31106 Ladies and Gentlemen: The comment and response set forth below are keyed to the]

By | 2016-03-17T14:21:32+00:00 December 31st, 2014|Categories: Chinese Stocks, IMOS, SEC Original|Tags: , , , , , |0 Comments

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] CORRESP: VIA EDGAR Division of Corporation Finance Mail Stop

[VIA EDGAR Division of Corporation Finance Mail Stop 4720 100 F Street, N.E. Attention: Brian Cascio, Accounting Branch Chief Andri Boerman December 31, 2014 Re: ChipMOS TECHNOLOGIES (Bermuda) LTD. Form 20-F for the Fiscal Year Ended December 31, 2013 Filed April 25, 2014 File No. 000-31106 Ladies and Gentlemen: The comment and response set forth below are keyed to the]

By | 2016-03-17T14:22:48+00:00 December 31st, 2014|Categories: Chinese Stocks, IMOS, Webplus ver|Tags: , , , , , |0 Comments

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 20-F/A: (Original Filing)

[EXPLANATORY NOTE This Form 20-F/A is being filed in response to a comment letter from the staff of the SEC to the Company dated December 16, 2014 (the “SEC Comment Letter”). We expect that the SEC Comment Letter and our response letter will be released in due course on the SEC’s Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system at] [CERTIFICATIONS I, Shih-Jye Cheng, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based] [CERTIFICATIONS I, Shou-Kang Chen, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based] [ChipMOS TECHNOLOGIES (Bermuda) LTD. CERTIFICATION Shih-Jye Cheng Chairman and Chief Executive Officer EX-13.1 4 d839261dex131.htm EX-13.1] [ChipMOS TECHNOLOGIES (Bermuda) LTD. CERTIFICATION Shou-Kang Chen Chief Financial Officer EX-13.2 5 d839261dex132.htm EX-13.2] [December 31, 2014 The Board of Directors ChipMOS TECHNOLOGIES (Bermuda) LTD. No. 1, R & D Road 1 Hsinchu Science Park Hsinchu City, 30076 Republic of China Mr. S.J. Cheng Attention: Dear Sirs, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT Yours faithfully, Certified Public Accountants Hong Kong EX-15.1 6 d839261dex151.htm EX-15.1]

By | 2016-03-17T14:24:33+00:00 December 31st, 2014|Categories: Chinese Stocks, IMOS, SEC Original|Tags: , , , , , |0 Comments

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 20-F/A: EXPLANATORY NOTE This Form 20-F/A is being filed

[EXPLANATORY NOTE This Form 20-F/A is being filed in response to a comment letter from the staff of the SEC to the Company dated December 16, 2014 (the “SEC Comment Letter”). We expect that the SEC Comment Letter and our response letter will be released in due course on the SEC’s Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system at] [CERTIFICATIONS I, Shih-Jye Cheng, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based] [CERTIFICATIONS I, Shou-Kang Chen, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based] [ChipMOS TECHNOLOGIES (Bermuda) LTD. CERTIFICATION Shih-Jye Cheng Chairman and Chief Executive Officer EX-13.1 4 d839261dex131.htm EX-13.1] [ChipMOS TECHNOLOGIES (Bermuda) LTD. CERTIFICATION Shou-Kang Chen Chief Financial Officer EX-13.2 5 d839261dex132.htm EX-13.2] [December 31, 2014 The Board of Directors ChipMOS TECHNOLOGIES (Bermuda) LTD. No. 1, R & D Road 1 Hsinchu Science Park Hsinchu City, 30076 Republic of China Mr. S.J. Cheng Attention: Dear Sirs, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT Yours faithfully, Certified Public Accountants Hong Kong EX-15.1 6 d839261dex151.htm EX-15.1]

By | 2016-03-17T14:25:38+00:00 December 31st, 2014|Categories: Chinese Stocks, IMOS, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0914ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0914ex32ii_tianyinpharma.htm CERTIFICATION]

By | 2016-03-19T15:04:02+00:00 December 31st, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q:

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0914ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0914ex32ii_tianyinpharma.htm CERTIFICATION]

By | 2016-03-19T15:04:55+00:00 December 31st, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar